Coronary calcium score in patients with post-surgical hypoparathyroidism

ABSTRACT Objective: This study aimed to evaluate the cardiovascular risk of patients with post-surgical hypoparathyroidism through coronary calcium score (CACS) evaluation and cardiovascular risk calculators. Subjects and methods: Patients with post-surgical hypoparathyroidism (HG = 29) were compared to a control group (CG = 29), matched by sex and age. Demographic and clinical data were captured by a questionnaire or patient files. Both groups performed a thoracic-computed tomography to evaluate the CACS and the cardiovascular risk was calculated by two risk calculators. Results: In the HG, the supplementation of calcium varied between 500 to 2,000 mg/day and the mean calcitriol was 0.5 ± 0.29 mcg/day. The mean serum calcium and phosphorus were 8.32 ± 0.68 and 4.92 ± 0.87 mg/dL, respectively, and in the range recommended for hypoparathyroidism. The Brazilian Society of Cardiology's risk calculator showed a difference among groups, with no patient in the HG with low risk, but the CACS was similar. A positive CACS in the HG was associated with obesity and high BMI but not with calcium and/or vitamin D supplementation. Conclusion: In conclusion, patients with hypoparathyroidism did not show increased CACS, and it was not related to supplementation.

Effect of muscle mass reduction on the progression of coronary artery calcification in maintenance hemodialysis patients / 中华肾脏病杂志

Objective:To evaluate the extent and progression of coronary artery calcification in maintenance hemodialysis (MHD) patients, and to explore the risk factors of rapid progression of coronary artery calcification in MHD patients.Methods:The patients who underwent MHD in the Huashan Hospital affiliated to Fudan University from January 1, 2013 to December 31, 2017 were enrolled. This study included cross-sectional study and prospective cohort study. Multi-slice spiral computed tomography was used to measure coronary artery calcification, and coronary artery calcium score (CACS) was calculated. In the cross-sectional study, 62 MHD patients were enrolled. According to baseline CACS, the patients were divided into low calcification group (CACS < 100) and high calcification group (CACS ≥ 100). The nutritional and bone mineral metabolism indexes were compared between the two groups. Multiple linear regression analysis was used to analyze the correlation between CACS and muscle mass and laboratory indicators. Since 6 patients were lost to follow-up, 56 MHD patients who were followed-up regularly were enrolled in the prospective cohort study. According to the progression of CACS, the patients were divided into slow progression group (ΔCACS/year < 100) and rapid progression group (ΔCACS/year ≥ 100). Logistic regression equation was used to analyze the risk factors of coronary calcification progression. Hosmer-Lemeshow goodness of fit test and receiver operating characteristic curve were used to evaluate the performance of multivariate logistic regression model.Results:In the cross-sectional study, the age of 62 patients was (62.34±10.82) years old, and the median dialysis age was 78 (39,139) months. Among the 33 male patients, compared with the low calcification group ( n=7), the high calcification group ( n=26) had older age ( t=-2.281, P=0.030) and higher blood triglyceride ( Z=-1.985, P=0.047), and there was no statistically significant difference in muscle mass between the two groups; among the 29 female patients, the muscle mass/height 2 ( t=-2.600, P=0.015) and serum calcium ( t=-2.641, P=0.014) in the high calcification group ( n=15) were both higher than those in the low calcification group ( n=14), and the hemoglobin level was lower ( t=2.531, P=0.018), and the difference in muscle mass between the two groups was not statistically significant. High sensitivity C-reactive protein ( β=0.425, P=0.022) was independently correlated with CACS in male patients, and muscle mass/extracellular water ( β=-0.580, P=0.001) was independently correlated with CACS in female patients. In the prospective cohort study, the age of 56 patients was (59.82±11.14) years old, and the median dialysis age was 82 (40, 146) months. There was no significant difference in all-cause mortality between slow progression group ( n=22) and rapid progression group ( n=34), but the proportion of cardiovascular events in rapid progression group was significantly higher than that in slow progression group ( P=0.017). Compared with the slow progression group, the rapid progression group had higher proportion of males ( χ2=4.791, P=0.029), older age ( Z=-2.131, P=0.038), lower baseline muscle mass/extracellular water ( Z=2.482, P=0.016) and high-density lipoprotein cholesterol ( t=2.133, P=0.042), and faster rate of muscle mass loss (Δmuscle mass·height -2·year -1) ( Z=-2.282, P=0.023). Multivariate logistic regression analysis results showed that muscle mass loss ( OR=0.089, 95% CI 0.010-0.792, P=0.030) and baseline CACS ( OR=1.003, 95% CI 1.000-1.005, P=0.021) were influencing factors for progression of coronary artery calcification in MHD patients. Conclusion:Increasing baseline CACS and rapid reduction in muscle mass are risk factors for the progression of coronary artery calcification in MHD patients.

Impact of statin use on major adverse cardiovascular events in patients with normal stress myocardial perfusion imaging and elevated coronary artery calcium score

INTRODUCTION@#Normal stress myocardial perfusion imaging (MPI) carries a favourable prognosis. Conversely, elevated coronary artery calcium (CAC) is associated with increased major adverse cardiovascular events (MACE). There is limited information on the prognosis and management of patients with elevated CAC and normal MPI. We aimed to assess the outcomes of patients with elevated CAC and normal MPI in relation to post-MPI statin use.@*METHODS@#A retrospective review of normal MPI with CAC score >300 was performed between 1 March 2016 and 31 January 2017 in a Singapore tertiary hospital. Patients with known atherosclerotic cardiovascular disease or left ventricular ejection fraction <50% on MPI were excluded. Patient demographics, prescriptions and MACE (cardiac death, nonfatal myocardial infarction and/or ischaemic stroke) at 24 months after MPI were traced using electronic records. Binary logistic regression was used to evaluate for independent predictors of MACE.@*RESULTS@#We included 311 patients (median age 71 years, 56.3% male), of whom 65.0% were on moderate to high-intensity statins (MHIS) after MPI. MACE was significantly lower in the post-MPI MHIS group (3.5% vs. 9.2%, P = 0.035). On univariate binary logistic regression, post-MPI MHIS use was the only significant predictor for MACE (odds ratio [OR] 0.355 [95% confidence interval (CI) 0.131-0.962], P = 0.042), even after multivariate adjustment (adjusted OR 0.363, 95% confidence interval 0.134-0.984, P = 0.046).@*CONCLUSION@#Post-MPI MHIS use is associated with lower MACE and is an independent negative predictor for 24-month MACE among patients with normal MPI and CAC >300.

Application of Targeted Coronary Angiography in the Diagnosis of Sudden Cardiac Death / 法医学杂志

OBJECTIVES@#To diagnose coronary artery stenosis by using the postmortem computed tomography angiography (PMCTA), and to explore the diagnostic value of PMCTA in sudden cardiac death.@*METHODS@#Six death cases were selected, and the contrast medium iohexol was injected under high pressure through femoral artery approach with 5F pigtail catheter to obtain coronary image data and then the data was analyzed. The results of targeted coronary imaging and coronary artery calcium score (CaS) were compared with the results of conventional autopsy and histopathological examination.@*RESULTS@#The autopsy and histopathological examination of cases with coronary artery stenosis obtained similar results in targeted coronary angiography, with a diagnostic concordance rate of 83.3%. Targeted coronary angiography could effectively show coronary artery diseases, and the CaS was consistent with the results of conventional autopsy and histopathological examination.@*CONCLUSIONS@#Targeted coronary angiography can be used as an effective auxiliary method for conventional autopsy in cases of sudden cardiac death.

Correlation between Impaired Aortic Distensibility and the Severity of Coronary Artery Disease and Calcium Scoring Measured by Cardiac CT

Background: Multi-Slice cardiac CT has evolved as a noninvasive imaging technique for evaluation of stenosis in the coronary arteries by what is called Coronary Computed Tomographic Angiography (CCTA), but it is also widely used in quantitative plaque assessments through Coronary Artery Calcium (CAC) scoring and plaque type identification ( soft or Mixed VS calcific) . Evaluation of aortic distensibility and aortic stiffness can also be performed through Multi-Slice Computed Tomography (MSCT) by calculating Aortic Distensibility Index (ADI) and Pulse Wave Velocity (PWV). Aim: To evaluate whether impaired Aortic Distensibility Index (ADI) and Aortic Stiffness measured by Cardiac CT is correlating with the severity of coronary artery disease and coronary calcium scoring in at-risk individuals (assessed by CCTA). Patients and Methods: We included 180 patients. Patients were classified into four groups according to their CAC score and according to the degree of stenosis based on CCTA. All patients in this study have underwent full history taking, short clinical examination including B.P. and H.R. measurements, standard ECG, routine laboratory investigations, and Multi-Slice CT Coronary Angiography (MSCT-CA). All patients underwent coronary artery calcium (CAC) scanning and CCTA, and their ADI and Aortic Stiffness were measured. Maximum systolic and maximum diastolic cross sectional-area (CSA) of ascending-aorta (AAo) was measured 15-mm above the left main coronary ostium. ADI was defined as: [(Systolic CSA –Diastolic CSA)/ (Diastolic CSA in X systemic-pulse-pressure) X 103]. Aortic stiffness was measured as PWV using Bramwell-Hill equation [1] [(3.57/ ?distensibility)]. Results: There were strong correlation between Aortic distensibility and Aortic stiffness (PWV) with degree of stenosis and coronary artery calcium. In patients stratified based on the degree of calcium scoring (CAC score), there was a statistically significant negative correlation between calcium scoring and the ADI (Pearson's r= -0.771, p<?.001), and a statistically significant positive correlation between calcium scoring and PWV (Pearson's r=0.817, p<?.001). In patients stratified based on the degree of stenosis, there was a statistically significant negative correlation between ADI and the Degree of stenosis (Pearson's r=-0.707, p<?.001), and there was a statistically significant positive correlation between PWV and the Degree of stenosis (Pearson's r=0.697, p<?.001). Conclusion: Impaired aortic distensibility strongly correlates with the severity of coronary atherosclerosis, degree of stenosis and coronary artery calcium. Addition of ADI to CAC and traditional risk factors provides incremental value to predict at-risk individuals.

Coronary artery calcium is associated with lpa gene variant RS7765803-C in Mexican mestizo population The GEA Project

ABSTRACT Background: Lipoprotein(a) [Lp(a)] levels are genetically determined; high levels are a risk factor for coronary disease, although their association with coronary artery calcium (CAC) is controversial. Objective: The objective of the study was to assess the association of LPA gene polymorphisms with CAC in a Mexican Mestizo population. Methods: We included 1594 subjects 35-70 years old. Six polymorphisms of the LPA gene were analyzed. CAC score was determined by tomography and Lp(a) serum levels by immunonephelometry. The association of LPA polymorphism with CAC and Lp(a) was evaluated by logistic regression. Results: The prevalence of Lp(a) ≥30 mg/dL was 10%, and of CAC >0 was 26.9%. Three polymorphisms were associated with high Lp(a) levels: rs10455872-G (p = 0.013), rs6907156-T (p = 0.021), and rs7765803-C (p = 0.001). Homozygotes (CC) for the rs7765803 variant compared with the G allele (CG + GG) carriers had higher Lp(a) levels (8.9 [3.3-23.9] vs. 4.9 [2.3-11.2] mg/dL; p = 0.015) and higher prevalence of CAC >0 (36.5% vs. 26.3%, p = 0.045) and were associated with CAC > 0 (odds ratio = 1.7, 95% confidence interval: 1.06-2.7; p < 0.026). The other polymorphisms were not associated with CAC. Conclusions: This is the first study to demonstrate in a Mexican Mestizo population that carriers of the rs7765803-C allele of LPA gene have 2.6 times greater risk for high Lp(a) values and 1.7 times higher risk for coronary artery disease.

Score de calcio coronario en la estratificación de riesgo cardiovascular / Coronary calcium score in cardiovascular risk stratification / Escore de cálcio coronariano na estratificação de risco cardiovascular

Resumen: La enfermedad cardiovascular (CV) es la primera causa de muerte en el mundo y en Uruguay. La prevención CV consiste en un enfoque clínico terapéutico dirigido a disminuir la morbimortalidad CV basado en el riesgo estimado de cada individuo. La estratificación de riesgo CV en individuos asintomáticos con el objetivo de guiar y establecer medidas de tratamiento preventivo es de crucial importancia. Para ello, en el mundo se utilizan scores de riesgo clínico que incluyen el score de riesgo Framingham, el SCORE y el Pooled Cohort Equations, entre otros. Sin embargo, estos scores no son herramientas perfectas de predicción. Los scores estiman el riesgo basado en la distribución del factor de riesgo en una población, mientras que el score de calcio coronario (SCC) es un marcador directo de aterosclerosis coronaria en un individuo determinado. En las últimas tres décadas, numerosos estudios han demostrado la utilidad del SCC como herramienta para la estratificación de riesgo CV. Es, por lo tanto, importante entender cómo, para qué y por qué se realiza.

Summary: Cardiovascular disease is the leading cause of death in the world and in Uruguay. Cardiovascular prevention consists of a therapeutic clinical approach with the objective of reducing cardiovascular morbidity and mortality based on the estimated cardiovascular risk of each person. Thus, cardiovascular risk stratification in asymptomatic individuals with the objective of guide and establish preventive treatment measures is of crucial importance. For this, clinical risk scores are used worldwide, including the Framingham risk score, the SCORE1 and the Pooled Cohort Equations2, among others. However, these risk scores are not perfect prediction tools. While these global risk scores estimate risk based on the distribution of the risk factor in a population, the coronary calcium score is a direct marker of coronary atherosclerosis in a given individual. In the last three decades, numerous studies have demonstrated the usefulness of the coronary calcium score as a cardiovascular risk stratification tool. It is therefore important to understand how, for what and why it is done.

Resumo: As doenças cardiovasculares são a principal causa de morte no mundo e o Uruguai. A prevenção cardiovascular consiste em uma abordagem clínica terapêutica que visa reduzir a morbimortalidade cardiovascular com base no risco cardiovascular estimado de cada indivíduo. Assim, a estratificação do risco cardiovascular em indivíduos assintomáticos com o objetivo de orientar e estabelecer medidas de tratamento preventivo é de importância crucial. Para isso, os escores de risco clínico são utilizados em todo o mundo, incluindo o escore de risco de Framingham, o SCORE1 e as equações de coorte agrupadas2, entre outros. No entanto, essas pontuações de risco não são ferramentas de previsão perfeitas. Embora essas pontuações globais de risco calculem o risco com base na distribuição do fator de risco em uma população, o escore de cálcio coronariano é um marcador direto da aterosclerose coronariana em um determinado indivíduo. Nas últimas três décadas, numerosos estudos demonstraram a utilidade do escore de cálcio coronariano como uma ferramenta para estratificação de risco cardiovascular. Portanto, é importante entender como, para quê e por que isso é feito.

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease

BACKGROUND/AIMS: Advanced hepatic fibrosis is associated with cardiovascular disease (CVD) in patients with nonalcoholic fatty liver disease (NAFLD). We investigated the association between noninvasive serum fibrosis markers and the coronary artery calcium score (CACS) in subjects with NAFLD. METHODS: We analyzed 665 NAFLD subjects without chronic liver disease or heart disease between 2011 and 2015. The noninvasive fibrosis markers that were used to evaluate the severity of hepatic fibrosis included the NAFLD fibrosis score (NFS), fibrosis-4 (FIB-4) score, Forn's index, and the aspartate aminotransferase to platelet ratio index (APRI). RESULTS: The areas under the receiver operating characteristics curves for the NFS, FIB-4 score, Forn's index and APRI for predicting CACS >100 were 0.689, 0.683, 0.659, and 0.595, respectively. According to the multivariate analysis, older age, increased body mass index (BMI), and decreased estimated glomerular filtration rate (eGFR) were significant factors associated with CACS >100. The NFS, FIB-4 score and APRI were significantly associated with CACS >100 after adjusting for age and gender (p=0.006, p=0.012, and p=0.012, respectively) and after adjusting for age, gender, BMI and eGFR (p=0.013, p=0.022, and p=0.027, respectively). Scores integrating noninvasive fibrosis markers and other risk factors improved the predictive accuracy. CONCLUSIONS: The NFS and FIB-4 score were associated with coronary atherosclerosis in subjects with NAFLD. Furthermore, scores integrating these noninvasive scores and risk factors for CVD showed good discriminatory power in predicting CACS >100. Therefore, noninvasive serum fibrosis markers may be useful tools for identifying NAFLD subjects at a high risk for CVD.

Association of coronary artery calcium score with calcification and degree of stenosis: An autopsy study

@#Introduction: Coronary artery disease (CAD) is a known cause of major cardiovascular events and calcium score (CS) has been developed as a marker of coronary atherosclerosis. Yet, the relationship between post mortem computed tomography (PMCT) CS with histologically observed calcification and the severity of coronary artery stenosis has not been widely explored and is still unclear. This study aims to determine the association between coronary artery PMCT CS with histologically observed calcification and degree of stenosis of coronary arteries in post-mortem cases. Materials & Methods: This was a cross-sectional study involving 101 subjects recruited from the National Institute of Forensic Medicine (IPFN) Hospital Kuala Lumpur (HKL) over a period of 15 months, from December 2012 until April 2014. PMCT CS of the coronary arteries was calculated using Agatston-Janowitz score. Histological presence of calcification was observed and the degree of stenosis was calculated using an image analysis technique. Results: PMCT CS increased with increasing severity of stenosis (p<0.001). PMCT CS showed a positive correlation with the presence of calcification (r=-0.82, p<0.001). Conclusion: Calcium score is strongly associated with coronary artery calcification and the degree of luminal stenosis in post mortem subjects. Thus, PMCT may be useful as a non-invasive tool in diagnosing CAD in the event that an autopsy is not possible.

Association of Subclinical Hypothyroidism with Cardiovascular Risk Factors and Coronary Artery Calcium Score

BACKGROUND: Few studies have investigated the association between subclinical hypothyroidism (SCH) and coronary artery calcification (CAC). This study investigated this association in patients who visited a health promotion center.METHODS: This study included patients who visited the Health Promotion Center at a University Hospital between January 2014 and December 2015. Serum thyroid stimulating hormone (TSH) level, free thyroxine level, and the CAC score (CACS) were measured in all patients. Patients were classified into euthyroid and SCH groups. An independent t-test and chi-squared test were performed to analyze the general characteristics. Patients were further classified into three groups based on serum TSH levels (serum TSH level < 4.0, 4.0–10, and >10 µIU/mL), and the one-way analysis of variance test was performed to assess the clinical differences among three groups. Partial correlation coefficients were calculated to assess the correlation between serum TSH levels and cardiovascular risk factors. Patients with CACS=0 were classified into the non-calcification group, and those with CACS >0 were classified into the calcification group. The odds ratios of SCH to CAC were analyzed using logistic regression analysis.RESULTS: Serum TSH levels were significantly associated with body mass index, waist circumference, high-density lipoprotein cholesterol, and triglyceride levels. The risk of obesity, diabetes, and high triglyceride levels (>150 mg/dL) was significantly higher in the SCH group. Moreover, the SCH group with TSH levels >10 µIU/mL showed a significant risk of CAC (odds ratio, 3.18; 95% confidence interval, 1.10–9.21).CONCLUSION: SCH with TSH levels >10 µIU/mL is independently associated with the CACS.

Razón entre grasa visceral y subcutánea como predictor de alteraciones cardiometabólicas / Ratio of visceral to subcutaneous fat as a predictor of cardiometabolic risk

RESUMEN La grasa visceral es una importante medida predictora de riesgo cardiometabólico, sin embargo, se ha sugerido que la razón entre los componentes visceral y subcutáneo (TAV/TAS ≥ 0,4) puede ser un indicador más apropiado para evaluar la predisposición para acumular grasa visceral (GV) y las alteraciones cardio-metabólicas. Objetivo: Evaluar la predisposición para acumular GV y su asociación con alteraciones cardio-metabólicas. Métodos: Estudio transversal con 147 individuos atendidos en un ambulatorio de un hospital en el Nordeste brasileño. Se evaluaron el TAV y el TAS por tomografía computarizada y se investigaron variables demgráficas, clínicas, antropométricas y factores de riesgo cardiometabólico. Resultados: El promedio de edad fue 52,7±13,2 años y se observó una elevada razón TAV/TAS de 0,79±0,29 en hombres y 0,54±0,22 en mujeres. Se correlacionó la razón TAV/TAS con perfil glucídico y puntuacion de calcio coronariano (PCC) (p< 0,05), mientras que el TAV aislado presentó correlación directa con colesterol no-HDL, triglicéridos (TG), razón TG/HDL, glicemia, hemoglobina glicosilada y PCC (p<0,05) e inversa con HDL-c (p= 0,001). Conclusiones: Se observó una elevada predisposición para la acumulación de TAV. La razón TAV/TAS presentó correlación con alteraciones cardiometabólicas, pero la concentración de TAV aislada se correlacionó con un número superior de parámetros, siendo en esta investigación un predictor más potente que la razón TAV/TAS para indicar esas alteraciones.

ABSTRACT Visceral fat is an important predictor of cardiometabolic risk, but evidence suggests that the ratio between visceral and subcutaneous fat (≥0.4) may be a more appropriate indicator to assess individual predisposition to accumulate visceral fat (VF) and predict cardiometabolic alterations. Objective: To evaluate the predisposition to accumulate VF and its association with cardiometabolic alterations. Methods: A cross-sectional study was conducted with 147 patients seen at a hospital in Northeast Brazil. VF and subcutaneous fat (SF) were evaluated by computed tomography and anthropometric and cardiometabolic risk factors were investigated. Results: The mean age was 52.7±13.2 years. Mean VF/SF ratio was high: 0.79±0.29 for men and 0.54±0.22 for women and was correlated with the glucose profile and coronary calcium score (CCA) (p< 0.05). VF was directly correlation with non-HDL cholesterol, triglycerides (TG), TG/HDL ratio, glycemia, glycated hemoglobin and CCA (p< 0.05) and inversely with HDL-c (p= 0.001). Conclusions: A high predisposition to VF accumulation was observed in the population. VF/SF ratio correlated with cardiometabolic alterations, but the concentration of isolated VF correlated with a higher number of parameters. In this investigation, VF alone was a more powerful predictor of cardiometabolic alterations than the ratio of VF/SF.

Association of Inter-Arm Systolic Blood Pressure Difference with Coronary Atherosclerotic Disease Burden Using Calcium Scoring

PURPOSE: There are no sufficient data on the correlation between inter-arm blood pressure (BP) difference and coronary atherosclerosis found using coronary artery calcium score (CACS). We aimed to investigate if the increased difference in inter-arm BP is independently associated with severity of CACS. MATERIALS AND METHODS: Patients who had ≥3 cardiovascular risk factors or an intermediate Framingham Risk Score (FRS; ≥10) were enrolled. Inter-arm BP difference was defined as the absolute difference in BP in both arms. Quantitative CACS was measured by using coronary computed tomography angiography with the scoring system. RESULTS: A total of 261 patients were included in this study. Age (r=0.256, p<0.001), serum creatinine (r=0.139, p=0.030), mean of right arm systolic BP (SBP; r=0.172, p=0.005), mean of left arm SBP (r=0.190, p=0.002), inter-arm SBP difference (r=0.152, p=0.014), and the FRS (r=0.278, p<0.001) showed significant correlation with CACS. The increased inter-arm SBP difference (≥6 mm Hg) was significantly associated with CACS ≥300 [odds ratio (OR) 2.17, 95% confidence interval (CI) 1.12–4.22; p=0.022]. In multivariable analysis, the inter-arm SBP difference ≥6 mm Hg was also significantly associated with CACS ≥300 after adjusting for clinical risk factors (OR 2.34, 95 % CI 1.06–5.19; p=0.036). CONCLUSION: An increased inter-arm SBP difference (≥6 mm Hg) is associated with coronary atherosclerotic disease burden using CACS, and provides additional information for predicting severe coronary calcification, compared to models based on traditional risk factors.

Coronary artery calcium score and coronary computed tomography angiography for patients with asymptomatic polyvascular (non-coronary) atherosclerosis

<p><b>INTRODUCTION</b>The primary endpoint of this study was to determine the prevalence of coronary artery disease (CAD) and coronary artery calcium score (CACS) using coronary computed tomography angiography (CCTA) among patients with polyvascular atherosclerosis (PVA). Secondary endpoints were to evaluate the prevalence of cardiovascular risk factors and determine the predictors of PVA.</p><p><b>METHODS</b>The presence of atherosclerotic disease was assessed using ultrasonographic vascular examination in 515 asymptomatic patients. All patients with presence of stenosis over 50% and moderate-to-severe cardiovascular risk profile underwent CCTA to identify atherosclerotic coronary disease.</p><p><b>RESULTS</b>Among 515 participants, 143 patients had no evidence of atherosclerotic plaque. Of the 372 patients with atherosclerotic plaque, 184 patients had single-vessel disease, 111 patients had double-vessel disease and 77 patients had triple-vessel disease; among these patients, those who also presented with stenosis > 50% underwent CCTA. Coronary stenosis categories included: normal (6.4%); haemodynamically insignificant (34.6%); intermediate (28.7%); significant (26.6%); and total artery occlusion (3.7%). Based on the coronary vessel involved, the patients were categorised as having single- (41.0%), double- (42.0%) or triple- (17.0%) coronary disease. CACS was significantly higher in patients with double- or triple-vessel disease when compared to those with single-vessel disease.</p><p><b>CONCLUSION</b>Our study confirmed not only the high sensitivity of CCTA for highlighting CAD, but also its negative predictive value for excluding the presence of coronary stenosis or ischaemia. We found good correlation between PVA and CACS, and were able to confirm the risk factors for PVA.</p>

Dynamic observation on optimal time of coronary angiography performed using 1 28-MSCT after taking nitroglycerin and its significance / 吉林大学学报(医学版)

Objective:To investigate the optimal time of coronary computed tomography angiography (CCTA) after taking nitroglycerine,and to provide basis for improving the image quantity of CCTA .Methods:43 patients underwent CCTA were scanned with coronary artery calcium score (CACS)after taking nitroglycerin 0,3,5 and 10 min.Then the diameters of the same coronary artery from the same anatomic location and the expanding rates were measured,and the change regular was analyzed with single factor analysis of variance of SPSS 17.0 software. Results:The average coronary artery expanding rate was 8% 3 min after taking nitroglycerin, and the difference was significant compared with 0 min (P0.05 ).Conclusion:Taking nitroglycerin can significantly expand the diameter of coronary arteries.It is necessary to perform CCTA during 5-1 0 min after taking nitroglycerine.

Association of Homocysteine Levels with Subclinical Coronary Atherosclerosis in Asymptomatic Subjects

BACKGROUND: Progression of atherosclerotic plaques is known to be correlated with elevated circulating homocysteine (Hcy). However, whether the level of Hcy is related with coronary atherosclerosis in the subclinical state is unclear. Therefore, we performed this study to investigate the relationship between blood Hcy levels and subclinical atherosclerosis in asymptomatic self-referred subjects. METHODS: We retrospectively enrolled 2,968 self-referred asymptomatic subjects (1,374 men, 1,594 women) who had undergone both coronary CT angiography (CCTA) and coronary artery calcium scoring. The relationships between atherosclerosis, Hcy, and other clinical factors were assessed. RESULTS: Higher levels of Hcy were related with age, male gender, body mass index (BMI), waist circumference, blood pressure, high density lipoprotein (HDL), triglyceride, blood glucose, HbA1c, hsCRP, and coronary artery calcium score (CACS). Coronary plaque was more frequently found in higher Hcy quartile groups (21.3%, 28.8%, 34.4%, and 34.3%, P50%) was also more frequent in higher Hcy quartile groups (1.8%, 5.4%, 5.0%, and 6.6%, P400) than the first quartile group. CONCLUSIONS: Blood Hcy levels were associated with an increased risk of the presence and extent of subclinical atherosclerosis in asymptomatic subjects.

Lack of Superiority for Soluble ST2 over High Sensitive C-Reactive Protein in Predicting High Risk Coronary Artery Calcium Score in a Community Cohort

PURPOSE: Soluble ST2 (sST2) is an emerging prognostic biomarker in patients with cardiovascular disease (CVD). A recent study showed that sST2 predicted incident hypertension. High sensitive C-reactive protein (hsCRP) has been a widely-used biomarker for risk-stratifying in CVD. We compared the abilities of sST2 and hsCRP to predict high risk coronary artery calcium score (CACS). MATERIALS AND METHODS: The CACS was assessed by cardiac computed tomography, and sST2 was measured in 456 subjects enrolled in the Mapo-gu community cohort. In accordance with the 2013 ACC/AHA guidelines, we defined the high risk CACS group as individuals with a CACS ≥300 Agatston units (AU). RESULTS: There were 99 (21.7%) subjects with a CACS ≥300 AU. There was a strong correlation between log sST2 and log hsCRP (r=0.128, p=0.006), and both log sST2 and log hsCRP showed significant associations with CACS (r=0.101, p=0.031 for sST2, r=0.101, p=0.032 for hsCRP). In net reclassification improvement (NRI) analysis, the NRI for hsCRP over sST2 was significant [continuous NRI 0.238, 95% confidence interval (CI) 0.001–0.474, integrated discrimination index (IDI) 0.022, p=0.035], while the NRI for sST2 over hsCRP was not significant (continuous NRI 0.212, 95% CI -0.255–0.453, IDI 0.002, p=0.269). CONCLUSION: sST2 does not improve net reclassification for predicting a high risk CACS. Using hsCRP provides superior discrimination and risk reclassification for coronary atherosclerosis, compared with sST2.

Role of Coronary Artery Calcium Scoring in Detection of Coronary Artery Disease according to Framingham Risk Score in Populations with Low to Intermediate Risks

Current guidelines recommend that coronary artery calcium (CAC) screening should only be used for intermediate risk groups (Framingham risk score [FRS] of 10%-20%). The CAC distributions and coronary artery disease (CAD) prevalence in various FRS strata were determined. The benefit to lower risk populations of CAC score-based screening was also assessed. In total, 1,854 participants (aged 40-79 years) without history of CAD, stroke, or diabetes were enrolled. CAC scores of > 0, ≥ 100, and ≥ 300 were present in 33.8%, 8.2%, and 2.9% of the participants, respectively. The CAC scores rose significantly as the FRS grew more severe (P 20% strata were 3.4%, 6.7%, 9.0%, and 11.6% (P 20%; P < 0.05). In conclusion, the yield of screening for significant CAC and occult CAD is low in the very low risk population but it rises in low and intermediate risk populations.

Waist Circumference as a Marker of Obesity Is More Predictive of Coronary Artery Calcification than Body Mass Index in Apparently Healthy Korean Adults: The Kangbuk Samsung Health Study

BACKGROUND: We aimed to assess the risk for coronary artery calcification (CAC) according to groups subdivided by body mass index (BMI) and waist circumference (WC) in apparently healthy Korean adults. METHODS: Thirty-three thousand four hundred and thirty-two participants (mean age, 42 years) in a health screening program were divided into three groups according to BMI: 25 kg/m² (obese). In addition, the participants were divided into two groups according to WC. Coronary artery calcium score (CACS) was measured with multi-detector computed tomography in all participants. Presence of CAC was defined as CACS >0. RESULTS: When logistic regression analysis was performed with the presence of CAC as the dependent variable, the risk for CAC increased as BMI increased after adjusting for confounding variables (1.102 [95% confidence interval (CI), 1.000 to 1.216]; 1.284 [95% CI, 1.169 to 1.410]; in the overweight and obese groups vs. the normal weight group). When the participants were divided into six groups according to BMI and WC, the subjects with BMI and WC in the obese range showed the highest risk for CAC (1.321 [95% CI, 1.194 to 1.461]) and those with BMI in the overweight range and WC in the obese range showed the second highest risk for CAC (1.235 [95% CI, 1.194 to 1.461]). CONCLUSION: Participants with obesity defined by both BMI and WC showed the highest risk for CAC. Those with BMIs in the overweight range but with WC in the obese range showed the second highest risk for CAC, suggesting that WC as a marker of obesity is more predictive of CAC than BMI.